Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

NCT: NCT04246281 · COMPLETED

NCT IDNCT04246281
StatusCOMPLETED
Start Date2020-06-17
Completion2026-04-27

Brief Summary

The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The device is cleared by the FDA for up to 60 days of use for the relief of chronic or acute pain (including back pain)

Frequently Asked Questions

What is The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain?

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain is a clinical trial registered under NCT04246281. Current status: COMPLETED.

What is the status of NCT04246281?

The current status of NCT04246281 (The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain) is: COMPLETED.

When did The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain start?

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain started on 2020-06-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑